These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26338965)

  • 1. miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts.
    Al-Ansari MM; Aboussekhra A
    Oncotarget; 2015 Oct; 6(30):30006-16. PubMed ID: 26338965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and p16
    Al-Khalaf HH; Amir M; Al-Mohanna F; Tulbah A; Al-Sayed A; Aboussekhra A
    Mol Cell Biol; 2017 Sep; 37(17):. PubMed ID: 28630279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16
    Al-Khalaf HH; Aboussekhra A
    Mol Carcinog; 2017 Mar; 56(3):985-999. PubMed ID: 27596953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.
    Al-Ansari MM; Hendrayani SF; Shehata AI; Aboussekhra A
    Oncogene; 2013 May; 32(18):2356-64. PubMed ID: 22751126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.
    Al-Ansari MM; Hendrayani SF; Tulbah A; Al-Tweigeri T; Shehata AI; Aboussekhra A
    Neoplasia; 2012 Dec; 14(12):1269-77. PubMed ID: 23308058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.
    Al-Rakan MA; Hendrayani SF; Aboussekhra A
    BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects.
    Hendrayani SF; Al-Khalaf HH; Aboussekhra A
    Neoplasia; 2013 Jun; 15(6):631-40. PubMed ID: 23730211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage.
    Al-Khalaf HH; Mohideen P; Nallar SC; Kalvakolanu DV; Aboussekhra A
    J Biol Chem; 2013 Dec; 288(49):35511-25. PubMed ID: 24163379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.
    Hendrayani SF; Al-Khalaf HH; Aboussekhra A
    J Biol Chem; 2014 Nov; 289(45):30962-76. PubMed ID: 25231991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16INK4a inhibits the proliferation of osteosarcoma cells through regulating the miR-146b-5p/TRAF6 pathway.
    Jiang M; Lu W; Ding X; Liu X; Guo Z; Wu X
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30643010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1β, tumor necrosis factor-α, and interferon-γ.
    Kutty RK; Nagineni CN; Samuel W; Vijayasarathy C; Jaworski C; Duncan T; Cameron JE; Flemington EK; Hooks JJ; Redmond TM
    Mol Vis; 2013; 19():737-50. PubMed ID: 23592910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling.
    Aljagthmi WA; Alasmari MA; Daghestani MH; Al-Kharashi LA; Al-Mohanna FH; Aboussekhra A
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
    Geraldo MV; Yamashita AS; Kimura ET
    Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
    Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
    Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT.
    Al-Khalaf HH; Aboussekhra A
    J Biol Chem; 2014 Nov; 289(45):31433-47. PubMed ID: 25261470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
    Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
    Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal.
    Yoon SO; Kim EK; Lee M; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
    Oncotarget; 2016 Jan; 7(3):2475-95. PubMed ID: 26673617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.
    Deng X; Wu B; Xiao K; Kang J; Xie J; Zhang X; Fan Y
    Cell Physiol Biochem; 2015; 35(1):71-82. PubMed ID: 25547151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle.
    Chouvarine P; Legchenko E; Geldner J; Riehle C; Hansmann G
    J Mol Med (Berl); 2019 Oct; 97(10):1427-1438. PubMed ID: 31338525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.